Indomethacin for symptomatic patent ductus arteriosus in preterm infants.

CONCLUSIONS: High-certainty evidence shows that indomethacin is effective in closing a symptomatic PDA compared to placebo or no treatment in preterm infants. Evidence is insufficient regarding effects of indomethacin on other clinically relevant outcomes and medication-related adverse effects. PMID: 33448032 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33448032?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - January 15, 2021 Category: General Medicine Authors: Evans P, O'Reilly D, Flyer JN, Soll R, Mitra S Tags: Cochrane Database Syst Rev Source Type: research